Skip to main content
SpringerLink
Log in

The Effects of Combined Treatment with Niacin and Chromium on the Renal Tissues of Hyperlipidemic Rats

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

In this study, 12 months old female Swiss albino rats were used. They were randomly divided into four groups. The animals of group I were fed with pellet chow. Group II were fed with pellet chow and treated with 250 μg/kg CrCl3.6H2o and 100 mg/kg niacinfor 45 days. Group III were fed a lipogenic diet consisting of 2% cholesterol, 0.5% cholicacidand 2%sun flower oil added to the pellet chow, andgiven 3%alcoholic water for 60 days. Group IV were fed with the same lipogeni cdiet for 60 day sand treated by gavage technique to rats at a dose of 250 mu/kg CrCl3.6H2O and 100 mg/kg niacin for 45 days, 15 days after experimental animals were rendered hyperlipidemic. At the 60th day, renal tissue and blood samples were taken from the animals. The sections were examined under light and electron microscopy. The degenerative changes were much more in the hyperlipidemic rats than the control group. The changes in renal tissue were also observed in hyperlipidemic animals given niacin and chromium. In the hyperlipidemic rats, renal glutathione levels decreased and renal lipid peroxidation levels, and serum urea and creatinine levels were increased. But, renal glutathione levels increased and lipid peroxidation levels and serum urea and creatinine levels decreased in hyperlipidemic rats given niacin and chromium. The purpose of this study was to investigate whether a protective effect of a combination of niacin and chromium is present on the renal tissue of hyperlipidemic rats or not. In conclusion, we can say that niacin and chromium do not have a protective effect on the morphology of the renal tissue of hyperlipidemic rats, except a protective effect on their biochemical parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Campbell JD: Lifestyle, minerals and health. Med Hypotheses 57: 521–531, 2001

    Article  PubMed  CAS  Google Scholar 

  2. Snively CS, Gutierrez C: Chronic kidney disease: prevention and treatment of common complications. Am Fam Physician 70: 1921–1928, 2004

    PubMed  Google Scholar 

  3. Kamanna VS, Roh DD, Kirschenbaum MA: Hyperlipidemia and kidney disease:concepts derived from histopathology and cell biology of the glomerulus. Histol Histopathol 13: 169–179, 1998

    PubMed  CAS  Google Scholar 

  4. Zambon A, Hokanson JE, Brown BG, Brunzell JD: Evidence for a new pathophysiological mechanism for coronary artery disease regression. Am Heart Assoc 99: 1959–1964, 1999

    CAS  Google Scholar 

  5. Imai Y, Suzuki H, Saito T, Tsuji I, Abe K, Saruta T: The effect of pravastatin on renal function and lipid metabolism in patients with renal dysfunction with hypertension and hyperlipidemia. Clin Exp Hypertens 21: 1345–1355, 1999

    PubMed  CAS  Google Scholar 

  6. Kumai T, Oonuma S, Kitaoka Y, Tadokoro M, Kobayashi S: Biochemical and morphological characterization of spontaneously hypertensive hyperlipidaemic rats. Clin Exp Pharmacol Physiol 30: 537–544, 2003

    Article  PubMed  CAS  Google Scholar 

  7. Madore F: Cardiac risk factors in renal disease. Med Sci 20: 1100–1103, 2004

    Google Scholar 

  8. Simonoff M: Chromium deficiency and cardiovascular risk. Cardiovas Res 18: 591–596, 1984

    CAS  Google Scholar 

  9. Bourn DM, Gibson RS Martinez OB, Macdonald AC: The effect of chromium supplementation on serum lipid levels in a selected sample of canadian postmenopausal women. Biol Trace Elem Res 9: 197–205, 1986

    CAS  Google Scholar 

  10. Anderson RA: Chromium metabolism its role in disease processes in man. Clin Physiol Biochem 4: 31–41, 1986

    PubMed  CAS  Google Scholar 

  11. Vincent JB: Elucidating a biological role for chromium at a molecular level. Acc Chem Res 33: 503–510, 2000

    Article  PubMed  CAS  Google Scholar 

  12. Cohen MD, Kargacin B, Klein CB, Costa M: Mechanisms of chromium carcinogenicity and toxicity. Crit Rev Toxicol 23: 255–281, 1993

    PubMed  CAS  Google Scholar 

  13. Morris B, Peacey SR, Macneil S, Gray T: Enhacement in insulin sensitivity in healthy volunteers following supplementation with chromium picolinate. Med Biochem 1: 65–72, 1998

    CAS  Google Scholar 

  14. Davies S, McLaren Howard J, Hunnisett A, Howard M: Age-related decreases in chromium levels in 51,665 hair, sweat and serum samples from 40,872 patients-implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism 46: 469–473, 1997

    Article  PubMed  CAS  Google Scholar 

  15. Rajpathak S, Rimm EB, Li T, Morris JS, Stampfer MJ, Willett WC, Hu FB: Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 27: 2211–2216, 2004

    PubMed  CAS  Google Scholar 

  16. Anderson RA: Nutritional role of chromium. Sci Total Environ 17: 13–29, 1981

    Article  PubMed  CAS  Google Scholar 

  17. Racek J: Chromium as an essential element. Cas Lek Cesk 142: 335–339, 2003

    PubMed  CAS  Google Scholar 

  18. Offenbacher EG, Pi-Sunyer FX: Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29: 919–925, 1980

    PubMed  CAS  Google Scholar 

  19. Wang MM, Fox EA, Stoecker BJ, Menendez CE, Chan SB: Serum cholesterol of adults supplemented with brewer&s yeast or chromium chloride. Nutr Res 9: 989–998, 1989

    Article  CAS  Google Scholar 

  20. Superko HR, Krauss RM: Differential effects of nicotinic acid in subjects with different LDL subclass patterns. Atherosclerosis 95: 69–76, 1992

    Article  PubMed  CAS  Google Scholar 

  21. Goldberg AC: Clinical trial experience with extended-release niacin (Niaspan): Dose- escalation study. Am J Cardiol 82: 35U–38U, 1998

    Article  PubMed  CAS  Google Scholar 

  22. 22 Capuzzi DM, Morgan JM, Brusco OA, Intenzo CM: Niacin dosing: relationship to benefits and adverse effects. Curr Atheroscler Rep 2: 64–71, 2000

    PubMed  CAS  Google Scholar 

  23. 23 Tavintharan S, Kashyap Benefits ML: The benefits of niacin in atherosclerosis. Curr Atheroscler Rep 3: 74–82, 2001

    PubMed  CAS  Google Scholar 

  24. 24 Morgan JM, Capuzzi DM, Guyton JR: A new extended-release niacin (niaspan): efficiacy, tolerabity, and safety in hypercholesterolemic patients. Am J Cardiol 82: 29U–34U, 1998

    Article  PubMed  CAS  Google Scholar 

  25. 25 Goldberg A, Alagona P, Capuzzi DM, Guyton J, Morgan JM, Rodgers J, Sachson R, Samuel P: Multiple-dose efficiacy and safety of an extended-release form of niacin in the management of hyperlipidemia. Am J Cardiol 85: 1100–1105, 2000

    Article  PubMed  CAS  Google Scholar 

  26. Anderson RA, Polansky MM, Bryden NA, Patterson KY, Veillon C, Glinsmann WH: Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters. J Nutr 113: 276–281, 1983

    PubMed  CAS  Google Scholar 

  27. Roeback JR, Hla KM, Chambles LE, Fletcher RH: Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. Ann Intern Med 115: 917–924, 1991

    PubMed  Google Scholar 

  28. Anderson RA, Bryden NA, Polansky MM, Gautschi, K: Dietary chromium effects on tissue chromium concentrations and chromium absorbtion in rats. J Trace Elem Exp Med 9: 11–25, 1996

    Article  CAS  Google Scholar 

  29. Anderson RA, Bryden NA, Evock-Clover CM, Steele NC: Benificial effects of chromium on glucose and lipid variables in control and somatotropin-treated pigs are associated with increased tissue chromium and altered tissue cooper, iron, and zinc. J Anim Sci 75: 657–661, 1997

    PubMed  CAS  Google Scholar 

  30. Kegley EB, Spears JW, Eisemann JH: Performance and glucose metabolism in calves fed a chromium-nicotinic acid complex or chromium chloride. J Dairy Sci 80: 1744–1750, 1997

    PubMed  CAS  Google Scholar 

  31. Rikans LL, Arata D, Cederquist DC: Fatty livers produced in albino rats by excess niacin in high fat diets. II Effect of choline supplements. J Nutr 85: 107–112, 1965

    PubMed  CAS  Google Scholar 

  32. Cohen L, Morgan J: Effectiveness of individualized long term therapy with niacin and probucol in reduction of serum cholesterol. J Fam Practice 26: 145–150, 1988

    CAS  Google Scholar 

  33. Brown BG, Bardsley J, Poulin D, Hillger LA, Dowdy A, Maher VMG, Zhao X-Q, Albers JJ, Knoop RH: Moderato dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low–density lipoprotein cholesterol<100 mg/dL in patients with hyperlipidemia and coronary artery disease. Am J Cardiol 80: 111–115, 1997

    Article  PubMed  CAS  Google Scholar 

  34. Guyton JR, Cappuzi DM: Treatment of hyperlipidemia with combined niacin-statin regimens. Am J Cardiol 82: 82U–84U, 1998

    Article  PubMed  CAS  Google Scholar 

  35. Preuss HG, Wallerstedt D, Talpur N, Tutuncuoglu SO, Echard B, Bui M, Bagchi D: Effect of niacin-bound chromium and grapeseed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: A pilot study. J Med 31: 227–246, 2000

    PubMed  CAS  Google Scholar 

  36. Ledwozyw A, Michalak J, Stepien A, Kadziolka A: The relationship plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 155: 275–284, 1986

    Article  PubMed  CAS  Google Scholar 

  37. Beutler E: Glutathione in red cell metabolism a manual of biochemical methods, 2nd edn. Grune and Stratton, New York, 1975, pp 112–114

  38. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951

    PubMed  CAS  Google Scholar 

  39. Barker SB: The direct colorimetric determination of urea in blood and urine. J Biol Chem 152: 453–463, 1944

    CAS  Google Scholar 

  40. Bonsnes RW, Taussky, HH: On the colorimetric determination of creatinine by the Jaffe Reaction. J Biol Chem 158: 581–591, 1945

    CAS  Google Scholar 

  41. Hintze JL: Copyright C. 865, East 400. North Kaysville, Utah, 84,037(801), 546–0445, 1986

  42. Tunez L, Munoz MC, Feijoo-Lopez AL, Valdvira E, Bujalance-Arenas L, Montilla P: Effect of melatonin on hyperlipidemic nephropathy under constant light exposure. J Physiol Biochem 58: 109–114, 2002

    Article  PubMed  CAS  Google Scholar 

  43. Rukkumani R, Sri, Balasubashini M, Vishwanathan P, Menon VP: Comparative effects of curcumin and photo-irradiated curcumin on alcohol-and polyunsaturated fatty acid-induced hyperlipidemia. Pharmacol Res 46: 257–264, 2002

    Article  PubMed  CAS  Google Scholar 

  44. Bolkent S, Yanardag R, Bolkent S, Doger MM: Beneficial effects of combined treatment with niacin and chromium on the liver of hyperlipemic rats. Biol Trace Elem Res 101: 219–230, 2004

    Article  PubMed  CAS  Google Scholar 

  45. Yanardag R, Peksel A, Yeŝilyaprak B. Doger MM, Arisan-Atac I: Effects of a combination of niacin and chromium (III)-chloride on the skin and lungs of hyperlipemic rats. Biol Trace Elem Res 103: 249–260, 2005

    Article  PubMed  CAS  Google Scholar 

  46. Scheuer H, Gwinner W, Hohbach J, Gröne EF, Brandes RP, Malle E, Olbricht CJ, Walli AK, Gröne HJ: Oxidant sterss in hyperlipidemia- induced renal damage. Am J Physiol Renal Physiol 278: F63–F74, 2000

    PubMed  CAS  Google Scholar 

  47. Mühlfeld AS, Spencer MW, Hudkins KL, LeBoeuf RC, Alpers CE: Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice. Kidney Int 66: 1393–1402, 2004

    Article  PubMed  Google Scholar 

  48. Hasegawa N, Yamda N, Mori M: Powdered green tea has antilipogenic effect on Zucker rats fed a high-fat diet. Phytother Res 17, 477–480, 2003

    Article  PubMed  Google Scholar 

  49. Devi R, Sharma DK: Hypolipidemic effect of different extracts of clerodendron colebrookianum Walp in normal and high-fat diet fed rats. J Etnopharmacol 90: 63–68, 2004

    Article  Google Scholar 

  50. Yamaguchi Y, Kagota S, Nakamura K, Shinozuka K, Kunitomo, M: Inhibitory effects of water extracts from fruiting bodies of cultured Cordyceps sinensis on raised serum lipid peroxide levels and aortic cholesterol deposition in atherosclerotic mice. Phytother Res 14: 650–652,2000

    Article  PubMed  CAS  Google Scholar 

  51. Ravi Deepa P, Varalakshmi P: Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis. Clin Chim Acta 339: 105–115, 2004

    Article  CAS  Google Scholar 

  52. Montilla P, Tunez I, Munoz MC, Lopez A, Soria JV: Hyperlipidemic nephropathy induced by adriamycin: Effect of melatonin administration. Nephron 76: 345–350, 1997

    Article  PubMed  CAS  Google Scholar 

  53. Malarkodi KP, Balachandar AV, Varlakshmi P: The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats. Mol Cell Biochem 247: 139–145, 2003

    Article  PubMed  CAS  Google Scholar 

  54. Olin KL, Stearns DM, Armstrong WH, Kean CL: Comparative retention/absorbtion of 51chromium 51Cr from 51Cr chloride, 51Cr nicotinate, and 51Cr picolinate in a rat model. Trace Elem Electroly 11: 182–186, 1994

    CAS  Google Scholar 

  55. Stearns DM, Wise Sr JP, Patierno SR, Wetterhahn KE: Chromium (III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J 9: 1643–1649, 1995

    PubMed  CAS  Google Scholar 

  56. Riales R, Albrink MJ: Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr 34: 2670–2678, 1981

    PubMed  CAS  Google Scholar 

  57. Preuss HG, Grojec PL, Lieberman S, Anderson RA: Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol 47 : 325–330, 1997

    PubMed  CAS  Google Scholar 

  58. Vinson JA, Mandarano MA, Shuta DL, Bagchi M, Bagchi D: Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model. Mol Cell Biochem 240: 99–103, 2002

    Article  PubMed  CAS  Google Scholar 

  59. Preuss HG, Grojec PL, Lieberman S, Anderson RA: Effects of different chromium compounds on blood pressure and lipid peroksidation in spontaneously hypertensive rats. Clin Nephrol 47: 325–330, 1997

    PubMed  CAS  Google Scholar 

  60. Knopp RH, Ginsberg J, Albers JJ, Hoff C, Ogilvie JT, Warnick GR, Burrows E, Retzlaff B, Poole M: Contrasting Effects of unmodified and time-release froms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin. Metabolism 34: 642–650, 1985

    Article  PubMed  CAS  Google Scholar 

  61. Angelin B, Eriksson M, Einarsson K: Combined treatment with colestyramine and nicotinic acid in heterozygous familial hypercolesterolaemia: effects on biliary lipid composition. Eur J Clin Invest 16: 391–396, 1986

    Article  PubMed  CAS  Google Scholar 

  62. Figge HL, Figge J, Souney PF, Mutnick AH, Sacks F: Nicotinic acid: A review of its clinical use in the treatment of lipid disorders. Ther Rev 8: 287–294, 1988

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology, Faculty of Science, Istanbul University, 34118, Vezneciler, İstanbul, Turkey

    Meliha Sengezer Inceli, Sehnaz Bolkent & M Mutluhan Doger

  2. Department of Chemistry, Faculty of Engineering, İstanbul University, 34320, Avcilar, Istanbul, Turkey

    Refiye Yanardag

Authors
  1. Meliha Sengezer Inceli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sehnaz Bolkent
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Mutluhan Doger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Refiye Yanardag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meliha Sengezer Inceli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inceli, M.S., Bolkent, S., Doger, M.M. et al. The Effects of Combined Treatment with Niacin and Chromium on the Renal Tissues of Hyperlipidemic Rats. Mol Cell Biochem 294, 37–44 (2007). https://doi.org/10.1007/s11010-006-9211-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-006-9211-x

Keywords

Search

Navigation